ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells

Yamagishi, 2003, Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy, Int J Clin Pharmacol Res, 23, 129

Kilhovd, 1999, Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease, Diabetes Care, 22, 1543, 10.2337/diacare.22.9.1543

Barlovic, 2011, RAGE biology, atherosclerosis and diabetes, Clin Sci (Lond), 121, 43, 10.1042/CS20100501

Dzau, 2002, Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies, Nat Med, 8, 1249, 10.1038/nm1102-1249

Sakata, 2000, Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells, J Atheroscler Thromb, 7, 169, 10.5551/jat1994.7.169

Bucciarelli, 2002, RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice, Circulation, 106, 2827, 10.1161/01.CIR.0000039325.03698.36

Bu, 2010, Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice, Circ Res, 106, 1040, 10.1161/CIRCRESAHA.109.201103

Klionsky, 2007, Autophagy: from phenomenology to molecular understanding in less than a decade, Nat Rev Mol Cell Biol, 8, 931, 10.1038/nrm2245

Yorimitsu, 2005, Autophagy: molecular machinery for self-eating, Cell Death Differ, 12, 1542, 10.1038/sj.cdd.4401765

Mizushima, 2007, How to interpret LC3 immunoblotting, Autophagy, 3, 542, 10.4161/auto.4600

Martinet, 2008, Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells, Br J Pharmacol, 154, 1236, 10.1038/bjp.2008.181

Kiffin, 2006, Oxidative stress and autophagy, Antioxid Redox Signal, 8, 152, 10.1089/ars.2006.8.152

Heymann, 2006, Autophagy: A protective mechanism in response to stress and inflammation, Curr Opin Investig Drugs, 7, 443

Codogno, 2003, Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells, J Biol Chem, 278, 16667, 10.1074/jbc.M210998200

Chiu, 2009, Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways, Autophagy, 5, 472, 10.4161/auto.5.4.7759

Hou, 1997, Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis, Kidney Int, 51, 1514, 10.1038/ki.1997.208

Mitsiades, 2002, Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications, Oncogene, 21, 5673, 10.1038/sj.onc.1205664

Creager, 2006, Advanced glycation end products - Sparking the development of diabetic vascular injury, Circulation, 114, 597, 10.1161/CIRCULATIONAHA.106.621854

Yoon, 2008, Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy, Exp Mol Med, 40, 398, 10.3858/emm.2008.40.4.398

Kawano, 1993, Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF beta-receptors, Eur J Clin Invest, 23, 84, 10.1111/j.1365-2362.1993.tb00745.x

Taniguchi, 1996, Involvement of glycation and oxidative stress in diabetic macroangiopathy, Diabetes, 45, 81, 10.2337/diab.45.3.S81

Basta, 2005, At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products, Arterioscler Thromb Vasc Biol, 25, 1401, 10.1161/01.ATV.0000167522.48370.5e

Xu, 2003, Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products, FASEB J, 17, 1289, 10.1096/fj.02-0490fje

Miyata, 1996, The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis, J Clin Invest, 98, 1088, 10.1172/JCI118889

Yamamoto, 1996, Advanced glycation endproducts-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B, Biochem Biophys Res Commun, 222, 700, 10.1006/bbrc.1996.0807

Shintani, 2004, Autophagy in health and disease: a double-edged sword, Science, 306, 990, 10.1126/science.1099993

Kockx, 1998, Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal, Circ Res, 83, 378, 10.1161/01.RES.83.4.378

Lander, 1997, Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress, J Biol Chem, 272, 17810, 10.1074/jbc.272.28.17810

Huttunen, 1999, Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappa B require the cytoplasmic domain of the receptor but different downstream signaling pathways, J Biol Chem, 274, 19919, 10.1074/jbc.274.28.19919